The government signs a fourth deal, securing doses of a treatment being developed by GSK and Sanofi.
This entry was posted
on Wednesday, July 29th, 2020 at 7:01 am and is filed under Business.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.